Rigel Pharmaceuticals
RIGL
RIGL
135 hedge funds and large institutions have $157M invested in Rigel Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 51 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% less capital invested
Capital invested by funds: $401M → $157M (-$244M)
71% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 34
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
135
Holding in Top 10
–
Calls
$1.19M
Puts
$584K
Top Buyers
| 1 | +$18.6M | |
| 2 | +$3.32M | |
| 3 | +$2.85M | |
| 4 |
Citigroup
New York
|
+$1.66M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.59M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$13.2M | |
| 3 | -$12M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$9.82M |
| 5 |
Walleye Capital
New York
|
-$3.14M |